Methods to Monitor Response to Chemotherapy in Non-Small Cell Lung Cancer with 18F-FDG PET
Corneline J. Hoekstra, MD1,2,
Otto S. Hoekstra, MD, PhD1,3,
Sigrid G. Stroobants, MD4,
Johan Vansteenkiste, MD, PhD5,
Johan Nuyts, PhD4,
Egbert F. Smit, MD, PhD2,
Maarten Boers, MD, PhD3,
Jos W.R. Twisk, PhD3 and
Adriaan A. Lammertsma, PhD1
1 Clinical PET Centre, VU University Medical Centre, Amsterdam, The Netherlands
2 Department of Pulmonary Medicine, VU University Medical Centre, Amsterdam, The Netherlands
3 Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
4 Department of Nuclear Medicine, University Hospital Gasthuisberg, Leuven, Belgium
5 Department of Pulmonary Medicine, University Hospital Gasthuisberg, Leuven, Belgium

View larger version (12K):
[in a new window]
|
FIGURE 1. Scatter plots of correlation between NLR and SUVBSAg (A), simplified kinetic method (B), and Patlak graphical analysis (C).
|
|
Copyright © 2002 by the Society of Nuclear Medicine.